about
Predicting progression of IgA nephropathy: new clinical progression risk score.Genome-wide association study identifies susceptibility loci for IgA nephropathy.Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.Native low-density lipoprotein uptake by macrophage colony-stimulating factor-differentiated human macrophages is mediated by macropinocytosis and micropinocytosis.The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progressionGWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathwayHeterogeneity of human macrophages in culture and in atherosclerotic plaquesATP-binding cassette (ABC) transporters mediate nonvesicular, raft-modulated sterol movement from the plasma membrane to the endoplasmic reticulum.A susceptibility gene for kidney disease in an obese mouse model of type II diabetes maps to chromosome 8.Fine Mapping Implicates a Deletion of CFHR1 and CFHR3 in Protection from IgA Nephropathy in Han Chinese.Novel mutations in the inverted formin 2 gene of Chinese families contribute to focal segmental glomerulosclerosis.Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study.Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series.Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 CasesProtein kinase C β and δ isoenzymes mediate cholesterol accumulation in PMA-activated macrophagesConstitutive receptor-independent low density lipoprotein uptake and cholesterol accumulation by macrophages differentiated from human monocytes with macrophage-colony-stimulating factor (M-CSF)
P50
Q31068314-66D6BD85-FA44-4C87-8B39-58D60A7E0A99Q34170453-B375BD50-A186-4610-86CA-D39627BC7529Q34318250-536215E9-9874-492C-9F44-0CC7AB9FAD69Q34422205-CB61AE68-8F45-4C22-A5F3-17C1E5096AC8Q35207040-B7D73703-8742-4B6F-9C31-C08CBD482823Q36237466-DE463795-DFA1-43E7-B206-813322B371EBQ36276884-2BFD2B0E-9C54-4D11-8B55-BAB84CD07ACDQ36512340-46548894-E773-4903-9097-F8DFE38C2EEAQ38337615-42033D32-338A-45B7-BFDB-1EE27DDC3AC0Q38949852-9A3706CD-06EE-4FFE-9DDC-86178F592154Q39950084-95A31E84-A89F-4A96-B39B-D9FEDE446AFEQ41697134-005E421C-40F4-4CA3-868A-7CF1EC3AE177Q47200770-783D6245-E9BB-423F-AEBD-28DCC34D7AE5Q48257502-E100E752-4A41-4A17-9D60-631534FA6E91Q59355839-2804CCC0-A3FF-4705-8F49-04E8FD2E8DEFQ60595343-33E2AABD-F370-4ECE-B4E9-8C4204EA70ADQ83135868-E8AD6157-D9FE-40EE-B0BA-DA28FAA5B7F4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yifu Li
@ast
Yifu Li
@en
Yifu Li
@es
Yifu Li
@nl
type
label
Yifu Li
@ast
Yifu Li
@en
Yifu Li
@es
Yifu Li
@nl
prefLabel
Yifu Li
@ast
Yifu Li
@en
Yifu Li
@es
Yifu Li
@nl
P106
P31
P496
0000-0002-7077-7689